argenx SE reported $486M in EBIT for its fiscal quarter ending in September of 2026.





Ebit Change Date
AstraZeneca USD 4.66B 1.5B Sep/2026
Genmab DKK 407M 221M Jun/2026
GlaxoSmithKline GBP 2.86B 251M Sep/2026
GRIFOLS EUR 394M 34M Sep/2026
Hikma Pharmaceutical USD 348M 31M Dec/2025
Lakefront Biotherapeutics EUR -41.17M 2.34M Sep/2026
Qiagen NV USD 141.4M 44.52M Jun/2026
UCB EUR 1.29B 571M Dec/2025